Compounded versions of popular drugs used for weight loss including Wegovy and Zepbound will soon no longer be available ...
Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.
Roche agreed to develop a weight-loss drug with Danish biotech Zealand Pharma, pressuring Novo Nordisk and Eli Lilly.
The Company has placed increased emphasis on its pharmacy gift card program to address the growing critical need for improved preventive care and affordable access to newer treatment options. By ...
10hon MSN
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...
The makers of weight-loss drugs Wegovy and Zepbound are cutting prices to make the medications more affordable for people without insurance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results